Cargando…
An International External Validation and Revision of the PsyMetRiC Cardiometabolic Risk Prediction Algorithm for Young People with Psychosis
INTRODUCTION: The comorbidity between cardiometabolic and psychotic disorders develops early. This is a crucial window of opportunity to reduce excess morbidity and mortality. Recently, a cardiometabolic risk prediction algorithm for young people with psychosis, the psychosis metabolic risk calculat...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9567930/ http://dx.doi.org/10.1192/j.eurpsy.2022.1741 |
_version_ | 1784809522272927744 |
---|---|
author | Perry, B. Vandenberghe, F. Osimo, E.F. Grosu, C. Piras, M. Jones, P. Mallikarjun, P. Stochl, J. Upthegrove, R. Khandaker, G. Eap, C. |
author_facet | Perry, B. Vandenberghe, F. Osimo, E.F. Grosu, C. Piras, M. Jones, P. Mallikarjun, P. Stochl, J. Upthegrove, R. Khandaker, G. Eap, C. |
author_sort | Perry, B. |
collection | PubMed |
description | INTRODUCTION: The comorbidity between cardiometabolic and psychotic disorders develops early. This is a crucial window of opportunity to reduce excess morbidity and mortality. Recently, a cardiometabolic risk prediction algorithm for young people with psychosis, the psychosis metabolic risk calculator (PsyMetRiC) was developed and externally validated in the UK. However, its international transportability is unknown. OBJECTIVES: We performed the first international validation study of PsyMetRiC in Lausanne, Switzerland, and examined whether additional variables (clinical and/or genetic) may improve the predictive performance of the algorithm METHODS: We included people aged 16-35y with psychosis from the PsyMetab cohort, who did not have MetS at baseline, and who had 1-6y follow-up data. The PsyMetRiC partial (age, sex, ethnicity, body mass index, smoking status, and prescription of a metabolically-active antipsychotic) and full (also including high-density lipoprotein and triglycerides) algorithms were applied. Predictive performance was assessed using measures of discrimination (C-statistic) and calibration (calibration plots). Recalibration steps included refitting the intercept and/or slope if necessary. Additional variables (e.g. speed of weight gain, polygenic risk scores) were added to the model and predictive performance was reassessed. RESULTS: We included 545 participants. The discrimination performance of both PsyMetRiC algorithms was good (C>0.75), and calibration plots showed good agreement between observed and predicted risk. Additional analyses to be conducted. CONCLUSIONS: PsyMetRiC is likely to be generalizable for use in Switzerland, suggesting that PsyMetRiC may also be suitable for use in other European populations. While additional international validations are required, these findings are an encouraging step toward an international cardiometabolic risk prediction algorithm for young people with psychosis. DISCLOSURE: No significant relationships. |
format | Online Article Text |
id | pubmed-9567930 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Cambridge University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-95679302022-10-17 An International External Validation and Revision of the PsyMetRiC Cardiometabolic Risk Prediction Algorithm for Young People with Psychosis Perry, B. Vandenberghe, F. Osimo, E.F. Grosu, C. Piras, M. Jones, P. Mallikarjun, P. Stochl, J. Upthegrove, R. Khandaker, G. Eap, C. Eur Psychiatry Abstract INTRODUCTION: The comorbidity between cardiometabolic and psychotic disorders develops early. This is a crucial window of opportunity to reduce excess morbidity and mortality. Recently, a cardiometabolic risk prediction algorithm for young people with psychosis, the psychosis metabolic risk calculator (PsyMetRiC) was developed and externally validated in the UK. However, its international transportability is unknown. OBJECTIVES: We performed the first international validation study of PsyMetRiC in Lausanne, Switzerland, and examined whether additional variables (clinical and/or genetic) may improve the predictive performance of the algorithm METHODS: We included people aged 16-35y with psychosis from the PsyMetab cohort, who did not have MetS at baseline, and who had 1-6y follow-up data. The PsyMetRiC partial (age, sex, ethnicity, body mass index, smoking status, and prescription of a metabolically-active antipsychotic) and full (also including high-density lipoprotein and triglycerides) algorithms were applied. Predictive performance was assessed using measures of discrimination (C-statistic) and calibration (calibration plots). Recalibration steps included refitting the intercept and/or slope if necessary. Additional variables (e.g. speed of weight gain, polygenic risk scores) were added to the model and predictive performance was reassessed. RESULTS: We included 545 participants. The discrimination performance of both PsyMetRiC algorithms was good (C>0.75), and calibration plots showed good agreement between observed and predicted risk. Additional analyses to be conducted. CONCLUSIONS: PsyMetRiC is likely to be generalizable for use in Switzerland, suggesting that PsyMetRiC may also be suitable for use in other European populations. While additional international validations are required, these findings are an encouraging step toward an international cardiometabolic risk prediction algorithm for young people with psychosis. DISCLOSURE: No significant relationships. Cambridge University Press 2022-09-01 /pmc/articles/PMC9567930/ http://dx.doi.org/10.1192/j.eurpsy.2022.1741 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Abstract Perry, B. Vandenberghe, F. Osimo, E.F. Grosu, C. Piras, M. Jones, P. Mallikarjun, P. Stochl, J. Upthegrove, R. Khandaker, G. Eap, C. An International External Validation and Revision of the PsyMetRiC Cardiometabolic Risk Prediction Algorithm for Young People with Psychosis |
title | An International External Validation and Revision of the PsyMetRiC Cardiometabolic Risk Prediction Algorithm for Young People with Psychosis |
title_full | An International External Validation and Revision of the PsyMetRiC Cardiometabolic Risk Prediction Algorithm for Young People with Psychosis |
title_fullStr | An International External Validation and Revision of the PsyMetRiC Cardiometabolic Risk Prediction Algorithm for Young People with Psychosis |
title_full_unstemmed | An International External Validation and Revision of the PsyMetRiC Cardiometabolic Risk Prediction Algorithm for Young People with Psychosis |
title_short | An International External Validation and Revision of the PsyMetRiC Cardiometabolic Risk Prediction Algorithm for Young People with Psychosis |
title_sort | international external validation and revision of the psymetric cardiometabolic risk prediction algorithm for young people with psychosis |
topic | Abstract |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9567930/ http://dx.doi.org/10.1192/j.eurpsy.2022.1741 |
work_keys_str_mv | AT perryb aninternationalexternalvalidationandrevisionofthepsymetriccardiometabolicriskpredictionalgorithmforyoungpeoplewithpsychosis AT vandenberghef aninternationalexternalvalidationandrevisionofthepsymetriccardiometabolicriskpredictionalgorithmforyoungpeoplewithpsychosis AT osimoef aninternationalexternalvalidationandrevisionofthepsymetriccardiometabolicriskpredictionalgorithmforyoungpeoplewithpsychosis AT grosuc aninternationalexternalvalidationandrevisionofthepsymetriccardiometabolicriskpredictionalgorithmforyoungpeoplewithpsychosis AT pirasm aninternationalexternalvalidationandrevisionofthepsymetriccardiometabolicriskpredictionalgorithmforyoungpeoplewithpsychosis AT jonesp aninternationalexternalvalidationandrevisionofthepsymetriccardiometabolicriskpredictionalgorithmforyoungpeoplewithpsychosis AT mallikarjunp aninternationalexternalvalidationandrevisionofthepsymetriccardiometabolicriskpredictionalgorithmforyoungpeoplewithpsychosis AT stochlj aninternationalexternalvalidationandrevisionofthepsymetriccardiometabolicriskpredictionalgorithmforyoungpeoplewithpsychosis AT upthegrover aninternationalexternalvalidationandrevisionofthepsymetriccardiometabolicriskpredictionalgorithmforyoungpeoplewithpsychosis AT khandakerg aninternationalexternalvalidationandrevisionofthepsymetriccardiometabolicriskpredictionalgorithmforyoungpeoplewithpsychosis AT eapc aninternationalexternalvalidationandrevisionofthepsymetriccardiometabolicriskpredictionalgorithmforyoungpeoplewithpsychosis AT perryb internationalexternalvalidationandrevisionofthepsymetriccardiometabolicriskpredictionalgorithmforyoungpeoplewithpsychosis AT vandenberghef internationalexternalvalidationandrevisionofthepsymetriccardiometabolicriskpredictionalgorithmforyoungpeoplewithpsychosis AT osimoef internationalexternalvalidationandrevisionofthepsymetriccardiometabolicriskpredictionalgorithmforyoungpeoplewithpsychosis AT grosuc internationalexternalvalidationandrevisionofthepsymetriccardiometabolicriskpredictionalgorithmforyoungpeoplewithpsychosis AT pirasm internationalexternalvalidationandrevisionofthepsymetriccardiometabolicriskpredictionalgorithmforyoungpeoplewithpsychosis AT jonesp internationalexternalvalidationandrevisionofthepsymetriccardiometabolicriskpredictionalgorithmforyoungpeoplewithpsychosis AT mallikarjunp internationalexternalvalidationandrevisionofthepsymetriccardiometabolicriskpredictionalgorithmforyoungpeoplewithpsychosis AT stochlj internationalexternalvalidationandrevisionofthepsymetriccardiometabolicriskpredictionalgorithmforyoungpeoplewithpsychosis AT upthegrover internationalexternalvalidationandrevisionofthepsymetriccardiometabolicriskpredictionalgorithmforyoungpeoplewithpsychosis AT khandakerg internationalexternalvalidationandrevisionofthepsymetriccardiometabolicriskpredictionalgorithmforyoungpeoplewithpsychosis AT eapc internationalexternalvalidationandrevisionofthepsymetriccardiometabolicriskpredictionalgorithmforyoungpeoplewithpsychosis |